Double-blind, placebo-controlled study of luteinising-hormone-releasing-hormone nasal spray in treatment of undescended testes

In a double-blind, placebo-controlled study, 252 prepubertal boys with 301 undescended testes were treated with luteinising-hormone-releasing-hormone (LHRH), 1.2 mg/day intranasally. After the 8-week double-blind period 10 placebo-treated (8%) and 14 LHRH-treated (9%) testes had completely descended...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of pediatric surgery 1986-04, Vol.1 (8486), p.876-880
Hauptverfasser:	DE MUINCK KEIZER-SCHRAMA, S. M. P. F, HAZEBROEK, F. W. J, MATROOS, A. W, DROP, S. L. S, MOLENAAR, J. C, VISSER, H. K. A
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intranasal Aerosols Age Factors Biological and medical sciences Child Child, Preschool Chorionic Gonadotropin - therapeutic use Clinical Trials as Topic Cryptorchidism - drug therapy Cryptorchidism - surgery Double-Blind Method Follow-Up Studies Genital system. Reproduction Gonadotropin-Releasing Hormone - administration & dosage Gonadotropin-Releasing Hormone - blood Humans Infant Male Medical sciences Pharmacology. Drug treatments Prognosis Random Allocation Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!